The Company's Board of Directors resolved to convene the 2022 Annual General Shareholders' Meeting (Location confirmed and electronic voting period amended)
· Issued by Applied BioCode Corp.
Close
Today's Information
Provided by: Applied BioCode Corporation
SEQ_NO
1
Date of announcement
2022/04/28
Time of announcement
16:17:35
Subject
The Company's Board of Directors resolved to
convene the 2022 Annual General Shareholders' Meeting
(Location confirmed and electronic voting period amended)
Date of events
2022/04/28
To which item it meets
paragraph 17
Statement
1.Date of the board of directors' resolution:2022/04/28
2.Shareholders meeting date:2022/06/13
3.Shareholders meeting location:Primasia Conference & Business Center
(15F.No.99,Fuxing North Road, Songshan, District, Taipei City, Taiwan)
4.Shareholders meeting will be held by means of (physical shareholders
meeting/ visual communication assisted shareholders meeting /
visual communication shareholders meeting):physical shareholders meeting
5.Cause for convening the meeting (1)Reported matters:
(1)2021 Operation Report
(2)Audit Committee's Review Report on the 2021 Financial Statements
6.Cause for convening the meeting (2)Acknowledged matters:
(1)2021 Business Report and 2021 Consolidated Financial Report
(2)2021 Deficit Compensation
7.Cause for convening the meeting (3)Matters for Discussion:
(1)Adoption of the Amended and Restated Memorandum and Articles
of Association
(2)Amendment to the "Rules of Procedure for the Shareholders' Meeting"
(3)Amendment to "Procedures for Acquisition or Disposal of Assets"
8.Cause for convening the meeting (4)Election matters:
(1)Election of New Directors and New Independent Directors
9.Cause for convening the meeting (5)Other Proposals:
(1)Release Non-Competition Covenants from All Newly Elected Directors
(Including Independent Directors)
10.Cause for convening the meeting (6)Extemporary Motions:None.
11.Book closure starting date:2022/04/15
12.Book closure ending date:2022/06/13
13.Any other matters that need to be specified:
(1)In accordance with Article 172-1 of ROC's Company Act,
the Company shall announce to public the premises and the period
during which the shareholders' written proposals and nominations
are accepted prior to the book closure date set for this General
Meeting of Shareholders:
1.Reception Period: April 8, 2022 to April 18, 2022
(before 5:00 PM).
2.Reception Office: Applied BioCode Taiwan, Ltd.
(Address: 6th Floor, No. 1, Lane 28, Xingzhong Road,
Neihu District, Taipei City 114, Taiwan (R.O.C.)
(2)Votes may be exercised by way of electronic transmission for
this Annual General Shareholders' Meeting.
Period of Exercise: May 10, 2022 and June 10, 2022.
The electronic voting platform: Taiwan Depository & Clearing
Corporation. Website:www.stockvote.com.tw
